Risk of Developing Pertussis Among Vaccinees According to Brand of Whole Cell Vaccine Received

Pediatric Research - United States
doi 10.1203/00006450-199904020-00952
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Whole-Cell and Acellular Pertussis Vaccination Programs and Rates of Pertussis Among Infants and Young Children

CMAJ
Medicine
2006English

Pertussis: Acellular, Whole-Cell, New Vaccines, What to Choose?

Expert Review of Vaccines
Molecular MedicineDrug DiscoveryImmunologyPharmacology
2016English

Proteomics of Bordetella Pertussis Whole-Cell and Acellular Vaccines

BMC Research Notes
BiochemistryMedicineGeneticsMolecular Biology
2019English

Pertussis Vaccine.

BMJ
1981English

Cell-Mediated Immune Response of Healthy Adults to Bordetella Pertussis Vaccine Antigens

Journal of Infectious Diseases
Infectious DiseasesAllergyImmunology
1998English

Toxicity of Pertussis Vaccine.

BMJ
1982English

Toxicity of Pertussis Vaccine.

BMJ
1982English

Oligosaccharide Conjugates of Bordetella Pertussis and Bronchiseptica Induce Bactericidal Antibodies, an Addition to Pertussis Vaccine

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
2011English

The Comparative Efficacy of the Lederle/Takeda Acellular Pertussis Component DTaP Vaccine and Lederle Whole-Cell Component DTP Vaccine in German Infants Following Household Exposure • 846

Pediatric Research
Child HealthPediatricsPerinatology
1998English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy